In two phase 3 trials published Oct. 21, 2026, in the New England Journal of Medicine, retatrutide reduced breathing pauses during sleep by up to 34.3 events per hour at 80 weeks…
A Danish nationwide study published Oct. 3, 2026, found that 8.2% of people with hidradenitis suppurativa started a GLP-1 drug vs. 5.7% with psoriasis and 3.2% of controls; HS treatments fell afterward,…
In a phase 3 trial published Oct. 30, 2026, in The Lancet Diabetes & Endocrinology, Japanese adults with obesity disease who took orforglipron, a once-daily GLP-1 pill, lost 5.9% to 8.7% of…
In a trial of lifestyle weight-loss treatment for binge-eating disorder with obesity, the share of physically active people rose from 18.2% to 49.1% after treatment and stayed at 48.0% a year later.…
In a nationwide study of more than 6 million Korean adults aged 20 to 39, published Oct. 27, 2026, in Annals of Internal Medicine, 10-year cancer incidence was 2.62% with class II…
In 2,380 adults who had weight-loss surgery, an artificial intelligence reading of the electrocardiogram showed a heart age 3.86 years older than real age before surgery, with a modest decline after the…
